The efficacy of vildagliptin on type 2 diabetic patients with basal-bolus insulin therapy in the short-term hospitalization (single-center, randomized, open-label, controlled study).
Not Applicable
- Conditions
- Type 2 Diabetes
- Registration Number
- JPRN-UMIN000011851
- Lead Sponsor
- ippon Medical School, Chiba-Hokusoh Hospital, Division of Endocrinology, Department of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
The subjects were excluded, if they were treated with insulin, DPP-4I or GLP-1 receptor agonist, have a history or evidence of liver or endocrine disease, recent myocardial infarction, cerebral vascular disease, heart failure, infectious disease, pregnancy or any carcinoma.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The daily profile of plasma glucose and serum lipid at discherge.
- Secondary Outcome Measures
Name Time Method the required dose of insulin infusion to maintain the blood glucose normal.